Median sternotomy and multiple lung resections for metastatic sarcomas.
In the attempt to apply salvage surgery to the majority of patients with pulmonary tumour relapse, we have adopted a new treatment plan consisting of early bilateral lung exploration and resection through median sternotomy in all cases of sarcoma with resectable lung metastases, including synchronous or previously resected ones. The present paper summarizes the early results achieved with this technique in 56 consecutive patients treated between 1985 and 1988. Perioperative mortality was zero, and morbidity negligible. Occult contralateral metastases were resected in about one third of subjects with monolateral clinical lesions. Overall actuarial survival from first pulmonary resection is 51% at 2 years and 35% at 3 years. A slightly more favourable trend is evident for solitary lesions but the difference is not statistically significant. No difference in survival is observed in relation to the initial disease-free interval or to the histological type. The majority of relapses occurred within 6 months of sternotomy (23/35) and were confined to the lungs (21/35). Ten of these 21 patients with pulmonary relapse have undergone further resection and 5 of them are alive, with a median survival of 28 months. Present results are encouraging as far as resectability and early recurrence rate are concerned. Median sternotomy appears a most valuable therapeutic approach to pulmonary metastases from sarcomas, being safe and effective in local control of disease, and compatible with further surgical management of pulmonary recurrences.
Pastorino
U
U
Division of Thoracic Surgery, National Tumor Institute, Milan, Italy.
Valente
M
M
Gasparini
M
M
Azzarelli
A
A
Santoro
A
A
Tavecchio
L
L
Casali
P
P
Ravasi
G
G
D000293:Adolescent; D000328:Adult; D001859:Bone Neoplasms / Q000473:pathology; D002648:Child; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary* / Q000601:surgery; D008297:Male; D008722:Methods; D008875:Middle Aged; D011013:Pneumonectomy; D011379:Prognosis; D011446:Prospective Studies; D012509:Sarcoma / Q000556:secondary* / Q000601:surgery; D013249:Sternum / Q000601:surgery*